ArticleTherapeutic advances in respiratory disease

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma.

Roberto W Dal Negro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.